Spondylectomy for Giant Cell Tumor After Denosumab Therapy-Reference-Cited by-同舟云学术

Spondylectomy for Giant Cell Tumor After Denosumab Therapy

Published:2016-02 Issue:3 Volume:41 Page:E178-E182
ISSN:0362-2436
Container-title:SPINE
language:en
Short-container-title:SPINE

Author:

de Carvalho Cavalcante Rodrigo Alves,Silva Marques Rômulo Alberto,Santos Vinicius Gonçalves dos,Sabino Eduardo,Fraga Ailton Cabral,Zaccariotti Vladimir Arruda,Arruda Joao Batista,Fernandes Yvens Barbosa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Orthopedics and Sports Medicine

Reference22 articles.

1. Giant-cell tumor of bone

2. GIANT-CELL TUMOUR OF BONE

3. Gene Expression of Osteoprotegerin Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Giant Cell Tumor of Bone

4. Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thoracic giant cell tumor after two total en bloc spondylectomies including one emergency surgery: A case report;World Journal of Clinical Cases;2024-06-06

2. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report;European Spine Journal;2023-06-15

3. Comparison of the prognostic factors of total en bloc spondylectomy and total piecemeal spondylectomy in patients with Enneking stage III giant cell tumor in the thoracic and lumbar spine;European Spine Journal;2022-11-16

4. Diagnosis and Treatment of Lumbar Giant Cell Tumor of the Spine: Update on Current Management Strategies;Diagnostics;2022-03-30

5. Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach;American Journal of Case Reports;2021-04-27